Evidence map›Paper›PMID 38324671›Full record

ArticleBiochemistry2024

Structural Characterization of 5-Substituted Pyrrolo[3,2-

Jade M Katinas, Md Junayed Nayeen, Mathew Schneider, Khushbu Shah, Alexandra N Fifer, Lily M Klapper, Abhishekh Sharma, Kishore Thalluri, Michael S Van Nieuwenhze, Zhanjun Hou and 3 more

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jade M KatinasDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Md Junayed NayeenSchool of Pharmacy & Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Mathew SchneiderBarbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University, 4100 John R, Detroit, Michigan 48201, United States.
Khushbu ShahSchool of Pharmacy & Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Alexandra N FiferDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Lily M KlapperDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Abhishekh SharmaSchool of Pharmacy & Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Kishore ThalluriDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Michael S Van NieuwenhzeDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Zhanjun HouBarbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University, 4100 John R, Detroit, Michigan 48201, United States.ORCID 0000-0001-5631-5202
Aleem GangjeeSchool of Pharmacy & Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.ORCID 0000-0002-5513-7616
Larry H MatherlyBarbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University, 4100 John R, Detroit, Michigan 48201, United States.ORCID 0000-0001-6860-8133
Charles E DannDepartment of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.ORCID 0000-0002-0117-9474
Indiana University Bloomington · USDuquesne University · USWayne State University · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Gregory L Hura · 2017 to 2026
$28.6M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORTR01CA053535 · NCI · WAYNE STATE UNIVERSITY · PI HOU, ZHANJUN, MATHERLY, LARRY H · 1993 to 2024
$6.3M
TRAINING PROGRAM IN THE BIOLOGY OF CANCERT32CA009531 · NCI · WAYNE STATE UNIVERSITY · PI Larry H Matherly · 1985 to 2026
$5.3M
Therapeutic Targeting Mitochondrial C1 MetabolismR01CA250469 · NCI · WAYNE STATE UNIVERSITY · PI DANN, CHARLES E., GANGJEE, ALEEM · 2021 to 2025
$3.0M
Graduate Training Program in Quantitative and Chemical Biology at Indiana University BloomingtonT32GM131994 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI JARED C LEWIS · 2019 to 2026
$2.4M
Graduate Program in Quantitative and Chemical Biology at Indiana University BloomT32GM109825 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI GIEDROC, DAVID P. · 2014 to 2018
$926k
NCI NIH HHS R01 CA053535NCI NIH HHS R01 CA250469NCI NIH HHS T32 CA009531NIGMS NIH HHS P30 GM124169NIGMS NIH HHS P41 GM103311NIGMS NIH HHS T32 GM109825NIGMS NIH HHS T32 GM131994
6 · The paper itself

Abstract

We previously discovered first-in-class multitargeted 5-substituted pyrrolo[3,2-

Identifiers

PMID38324671
PMCPMC11303599
OpenAlexW4391617718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.